Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase.

[1]  R. Lisak,et al.  Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis. , 2013, Autoimmunity reviews.

[2]  J. Verschuuren,et al.  Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4. , 2013, Autoimmunity reviews.

[3]  S. Tzartos,et al.  Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens. , 2013, Autoimmunity reviews.

[4]  A. Marx,et al.  The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. , 2013, Autoimmunity reviews.

[5]  K. Shigemoto,et al.  Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis. , 2013, Autoimmunity reviews.

[6]  R. Mantegazza,et al.  Autoimmune mechanisms in myasthenia gravis. , 2012, Current opinion in neurology.

[7]  S. Gay,et al.  Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? , 2012, Autoimmunity reviews.

[8]  R. Lewis,et al.  Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. , 2012, Archives of neurology.

[9]  A. Miyazawa,et al.  Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis. , 2012, The American journal of pathology.

[10]  J. Verschuuren,et al.  Long-lasting treatment effect of rituximab in MuSK myasthenia , 2012, Neurology.

[11]  A. Masuda,et al.  Anti-MuSK autoantibodies block binding of collagen Q to MuSK , 2011, Neurology.

[12]  Shuo Lin,et al.  Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice , 2011, Experimental Neurology.

[13]  I. Evdokimidis,et al.  MRI Evidence of Early Muscle Atrophy in MuSK Positive Myasthenia Gravis , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[14]  D. Sanders,et al.  Anti‐musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts , 2011, Muscle & nerve.

[15]  X. Bosch,et al.  Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases , 2011, Pharmacological Reviews.

[16]  Y. Yamanashi,et al.  Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis , 2011, Annals of neurology.

[17]  D. Sanders,et al.  Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis. , 2010, Current opinion in neurology.

[18]  A. Gomez,et al.  Antibody effector mechanisms in myasthenia gravis—Pathogenesis at the neuromuscular junction , 2010, Autoimmunity.

[19]  D. Sanders,et al.  Immunosuppressive therapies in myasthenia gravis , 2010, Autoimmunity.

[20]  S. Kuwabara,et al.  Is tongue atrophy reversible in anti-MuSK myasthenia gravis? Six-year observation , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  S. Berrih-Aknin,et al.  Thymic remodeling associated with hyperplasia in myasthenia gravis , 2010, Autoimmunity.

[22]  M. Farrugia,et al.  The use of rituximab in myasthenia gravis and Lambert–Eaton myasthenic syndrome , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  Y. Levy,et al.  Geoepidemiology of myasthenia gravis [corrected]. , 2010, Autoimmunity reviews.

[24]  M. Pasnoor,et al.  Clinical findings in MuSK‐antibody positive myasthenia gravis: A U.S. experience , 2010, Muscle & nerve.

[25]  D. Isenberg,et al.  Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis. , 2009, Autoimmunity reviews.

[26]  H. Kwiecinski,et al.  Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy , 2009, Journal of Neurology.

[27]  Shin J Oh.  Muscle-Specific Receptor Tyrosine Kinase Antibody Positive Myasthenia Gravis Current Status , 2009, Journal of clinical neurology.

[28]  S. Hemmi,et al.  Racial differences in myasthenia gravis in Alabama , 2009, Muscle & nerve.

[29]  M. Marino,et al.  HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5 , 2009, Neurology.

[30]  D. Sanders,et al.  MuSK-antibody positive myasthenia gravis: Questions from the clinic , 2008, Journal of Neuroimmunology.

[31]  R. Blesa,et al.  Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients , 2008, Journal of Neuroimmunology.

[32]  A. Vincent,et al.  MuSK‐positive myasthenia gravis is rare in the Polish population , 2008, European journal of neurology.

[33]  S. Servidei,et al.  Response to Therapy in Myasthenia Gravis with Anti‐MuSK Antibodies , 2008, Annals of the New York Academy of Sciences.

[34]  Richard J. Jones,et al.  Rebooting the Immune System with High‐Dose Cyclophosphamide for Treatment of Refractory Myasthenia Gravis , 2008, Annals of the New York Academy of Sciences.

[35]  S. Kaveri,et al.  Role of natural antibodies in immune homeostasis: IVIg perspective. , 2008, Autoimmunity reviews.

[36]  H. Müller-Hermelink,et al.  Common Cellular and Diverse Genetic Basis of Thymoma‐associated Myasthenia Gravis , 2008, Annals of the New York Academy of Sciences.

[37]  R. Barohn.  Treatment and Clinical Research in Myasthenia Gravis , 2008, Annals of the New York Academy of Sciences.

[38]  A. Vincent,et al.  Myasthenia Gravis Seronegative for Acetylcholine Receptor Antibodies , 2008, Annals of the New York Academy of Sciences.

[39]  K. Shigemoto,et al.  Clinical and experimental features of MuSK antibody positive MG in Japan , 2007, European journal of neurology.

[40]  W. J. Hamilton,et al.  ANTI-MUSK ANTIBODY AFTER THYMECTOMY IN A PREVIOUSLY SEROPOSITIVE MYASTHENIC CHILD , 2007, Neurology.

[41]  R. Blesa,et al.  Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome , 2007, Nature Clinical Practice Neurology.

[42]  M. García-Carrasco,et al.  Therapeutic options in autoimmune myasthenia gravis. , 2007, Autoimmunity reviews.

[43]  G. Wolfe,et al.  Clinical Review of Muscle-Specific Tyrosine Kinase-Antibody Positive Myasthenia Gravis , 2007 .

[44]  Y. Parman,et al.  Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis , 2007, Neurology.

[45]  F. Ciaraffa,et al.  Anti-MuSK antibodies: Correlation with myasthenia gravis severity , 2006, Neurology.

[46]  R. Flink,et al.  Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody , 2006, Muscle & nerve.

[47]  A. Vincent,et al.  Strong association of MuSK antibody–positive myasthenia gravis and HLA-DR14-DQ5 , 2006, Neurology.

[48]  P. Matthews,et al.  MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. , 2006, Brain : a journal of neurology.

[49]  F. Hanisch,et al.  MuSK–antibody positive pure ocular myasthenia gravis , 2006, Journal of Neurology.

[50]  G. Wolfe,et al.  Repetitive nerve stimulation of facial muscles in musk antibody–positive myasthenia gravis , 2006, Muscle & nerve.

[51]  A. Weinacker,et al.  High‐dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies , 2006, Muscle & nerve.

[52]  A. Vincent,et al.  MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo , 2005, Journal of Neuroimmunology.

[53]  S. Oh,et al.  Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG , 2005, Neurology.

[54]  A. Vincent,et al.  Thymus changes in anti-MuSK-positive and -negative myasthenia gravis , 2005, Neurology.

[55]  D. Sanders,et al.  MuSK-antibody positive myasthenia gravis: Clinical and electrodiagnostic patterns , 2005, Clinical Neurophysiology.

[56]  M. D. de Baets,et al.  The features of myasthenia gravis with autoantibodies to MuSK , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[57]  N. Gilhus,et al.  Seronegative myasthenia gravis: disease severity and prognosis , 2005, European journal of neurology.

[58]  S. Ikeda,et al.  Myasthenia gravis with anti-MuSK antibody, showing progressive muscular atrophy without blepharoptosis. , 2005, Internal medicine.

[59]  A. Marx,et al.  Fewer thymic changes in MuSK antibody‐positive than in MuSK antibody‐negative MG , 2005, Annals of neurology.

[60]  A. C. Bragdon.  Treatment of autoimmune myasthenia gravis , 2004, Neurology.

[61]  A. Vincent,et al.  Clinical comparison of muscle‐specific tyrosine kinase (MuSK) antibody‐positive and ‐negative myasthenic patients , 2004, Muscle & nerve.

[62]  John C. Keesey,et al.  Clinical evaluation and management of myasthenia gravis , 2004, Muscle & nerve.

[63]  P. Tonali,et al.  Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. , 2003, Brain : a journal of neurology.

[64]  L. Phillips.  The Epidemiology of Myasthenia Gravis , 2003, Neurologic clinics.

[65]  Richard J. Jones,et al.  Treatment of refractory myasthenia: “Rebooting” with high‐dose cyclophosphamide , 2003, Annals of neurology.

[66]  D B Sanders,et al.  AAEM minimonograph #25: Single‐fiber electromyography , 1996, Muscle & nerve.

[67]  L. Phillips,et al.  Diagnosis of Myasthenia Gravis in the 1990s , 1990, Seminars in neurology.

[68]  N. Maggiano,et al.  Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. , 2005, Neurology.